Table 3.
Comparison of the EORTC-QLQ-C30 scores between the two groups at relative time points (mean ± SD).
| Domain | 6 months |
12 months |
||||
|---|---|---|---|---|---|---|
| TEAS group (n = 55) | Sham-TEAS group (n = 55) | P-valuea | TEAS group (n = 55) | Sham-TEAS group (n = 55) | P-valuea | |
| Function scale | ||||||
| Physical function | 93.82 ± 10.01 | 92.73 ± 9.45 | 0.311 | 91.64 ± 10.20 | 92.24 ± 9.50 | 0.772 |
| Role function | 95.15 ± 10.48 | 91.52 ± 13.56 | 0.078 | 92.73 ± 12.32 | 90.61 ± 14.26 | 0.385 |
| Emotional function | 96.82 ± 9.28 | 91.67 ± 11.79 | 0.002 | 95.45 ± 11.21 | 92.58 ± 10.60 | 0.024 |
| Cognitive function | 92.73 ± 14.26 | 90.30 ± 11.87 | 0.09 | 90.91 ± 16.30 | 89.09 ± 12.92 | 0.164 |
| Social function | 96.36 ± 9.99 | 97.58 ± 8.13 | 0.529 | 96.36 ± 9.99 | 97.58 ± 8.13 | 0.529 |
| Symptom scale | ||||||
| Fatigue | 6.67 ± 12.58 | 11.92 ± 13.16 | 0.01 | 10.71 ± 14.18 | 13.94 ± 13.73 | 0.151 |
| Nausea and vomiting | 0 | 2.42 ± 10.35 | 0.043 | 0 | 0.30 ± 2.24 | 0.317 |
| Pain | 3.64 ± 8.30 | 7.58 ± 11.03 | 0.032 | 2.73 ± 7.70 | 5.45 ± 10.17 | 0.092 |
| Dyspnea | 21.82 ± 20.51 | 29.70 ± 34.94 | 0.236 | 16.97 ± 16.82 | 21.21 ± 19.63 | 0.299 |
| Sleep disturbance | 10.91 ± 19.30 | 18.18 ± 27.08 | 0.198 | 12.12 ± 20.65 | 16.36 ± 24.74 | 0.429 |
| Appetite loss | 6.67 ± 17.45 | 12.73 ± 23.56 | 0.106 | 5.45 ± 14.00 | 7.88 ± 16.93 | 0.439 |
| Constipation | 6.06 ± 17.0 | 12.12 ± 22.56 | 0.093 | 4.85 ± 14.93 | 6.06 ± 15.83 | 0.584 |
| Diarrhea | 3.64 ± 12.29 | 3.03 ± 11.61 | 0.734 | 2.42 ± 8.74 | 1.21 ± 6.30 | 0.403 |
| Financial difficulties | 2.42 ± 8.74 | 0.61 ± 4.50 | 0.172 | 2.42 ± 8.74 | 0.60 ± 4.50 | 0.172 |
| Global health | 75.61 ± 10.98 | 70 ± 10.71 | 0.007 | 74.70 ± 11.78 | 69.70 ± 11.82 | 0.029 |
Abbreviations: EORTC-QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire.
a
Indicates Mann-Whitney U test.